StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.29+0.02 (+0.07%)

Close on Nov 18, 2026Market cap $1.69BP/E –Yield –

Kestra Medical Technologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Kestra Medical Technologies's operating income for the twelve months ending Jul 31, 2026 was -$143.52M. For fiscal 2026 it was -$134.74M.

Annual operating income

PeriodPeriod endValueChange
FY2026Apr 30, 2026-$134.74M–
FY2025Apr 30, 2025-$106.38M–
FY2024Apr 30, 2024-$85.06M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026-$37.66M–
Q4 FY2026CQ1 2026Apr 30, 2026-$39.34M–
Q3 FY2026CQ4 2025Jan 31, 2026-$34.77M–
Q2 FY2026CQ3 2025Oct 31, 2025-$31.76M–
Q1 FY2026CQ2 2025Jul 31, 2025-$28.88M–
Q4 FY2025CQ1 2025Apr 30, 2025-$48.21M–
Q3 FY2025CQ4 2024Jan 31, 2025-$20.60M–
Q2 FY2025CQ3 2024Oct 31, 2024-$19.13M–
Q1 FY2025CQ2 2024Jul 31, 2024-$18.43M–

More Kestra Medical Technologies figures

See a number that looks wrong?